about
Effects of cysteinyl leukotrienes in small human bronchus and antagonist activity of montelukast and its metabolitesDetermination of structure and transcriptional regulation of CYSLTR1 and an association study with asthma and rhinitisCysteinyl Leukotrienes and Their Receptors: Emerging Therapeutic Targets in Central Nervous System DisordersRole of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonistIdentification in mice of two isoforms of the cysteinyl leukotriene 1 receptor that result from alternative splicingAntileukotriene agents in asthma: the dart that kills the elephant?ALOX5 polymorphism associates with increased leukotriene production and reduced lung function and asthma control in children with poorly controlled asthmaEndogenous S-nitrosoglutathione modifies 5-lipoxygenase expression in airway epithelial cellsMontelukast: data from clinical trials in the management of asthma.Leukotriene D4-induced activation of smooth-muscle cells from human bronchi is partly Ca2+-independent.Influence of leukotriene pathway polymorphisms on response to montelukast in asthma.Review of psychosocial stress and asthma: an integrated biopsychosocial approach.Biochemistry and physiology of the leukotrienes.The enzymology and pharmacology of 5-lipoxygenase and 5-lipoxygenase activating protein.New perspectives for asthma treatment: anti-leukotriene drugs.Pharmacotherapy of asthma in children, with special reference to leukotriene receptor antagonists.Leukotriene C4 synthase. A pivotal enzyme in the biosynthesis of the cysteinyl leukotrienes.Asthma in sickle cell disease: implications for treatment.Montelukast: a review of its therapeutic potential in persistent asthma.Role of leukotrienes in asthma pathophysiology.Potential use of lipoxygenase inhibitors for cancer chemoprevention.Leukotriene A4 hydrolase in human bronchoalveolar lavage fluid.Antileukotrienes in asthma: present situation.Role of mast cells in anaphylaxis. Evidence for the importance of mast cells in the cardiopulmonary alterations and death induced by anti-IgE in mice.Modulation of mast cell proliferative and inflammatory responses by leukotriene d4 and stem cell factor signaling interactions.Exercise-induced bronchospasm in the elite athlete.Nitric oxide: a regulator of mast cell activation and mast cell-mediated inflammation.Differential regulation of cysteinyl leukotriene receptor signaling by protein kinase C in human mast cellsIncrease in urinary leukotriene LTE4 levels in acute asthma: correlation with airflow limitationAttenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005Effect of pranlukast, an oral leukotriene receptor antagonist, on leukotriene D4 (LTD4) challenge in normal volunteersSputum tumour necrosis factor-alpha and leukotriene concentrations in cystic fibrosisLeukotriene E4 activates human Th2 cells for exaggerated proinflammatory cytokine production in response to prostaglandin D2.Altered inflammatory responses in leukotriene-deficient miceEffect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patientsInteractions between airway epithelium and mediators of inflammation.Clinical experience with MK-571. A potent and specific LTD4 receptor antagonist.The preclinical and clinical pharmacology of SK&F 104353, a potent and selective peptidoleukotriene receptor antagonist.Transcript signatures of lymphocytic bronchitis in lung allograft biopsy specimensReduction in leukotriene B4 generation by bronchoalveolar lavage cells in asthma.
P2860
Q28187082-F3C75941-8503-4C65-9BDB-1BE95EE9E727Q28245735-D86D66BC-77F9-4791-8C61-5BDD5957C2D8Q28278005-15A7E6C8-3565-4671-8790-D6F6D9B648DAQ28319336-4CE2BF0C-59AC-4052-884A-55192C06C706Q28506159-DD2A0457-2A73-4733-A669-A3536F03BA2AQ28769366-CAF47605-AC80-48EC-A52C-74F6D2EF8695Q30413299-81D5B115-3395-4F81-92E0-3C2FC9A393D8Q30439239-089F187E-F46F-4D2D-8D26-DF04AD149923Q31448541-A3756737-8721-4781-8981-918F3025B6D7Q32033165-81B02C4C-CB43-46D8-80C4-A7AC56A5774CQ33227414-42DA426E-F7F1-4531-8BB0-DD84D06F653EQ33589349-9231687A-5385-473B-91EE-62368E856E11Q33705464-654501CC-F81E-4F39-A973-311FA44751D4Q33705482-D8A69D2B-C987-4C13-878E-D6F3F0C96AF5Q33729339-B3B6FB17-BC81-4F22-B9FF-AD883655398BQ33805187-7ACEEC1D-704F-4105-9074-9B8FA4BABF28Q33836679-99C97EFC-23A1-4B07-80EE-5ECFE28EB845Q33872120-6C5AFAD7-5D67-4697-A705-E8BB4EA7AC85Q33914371-8C9CDE26-B92A-4BB7-8248-F9D37372879FQ33988564-7E1C5BF5-51C9-403A-924C-C6E43AC5A8A3Q34075076-5480609F-8A28-487C-B2FD-7051EB8A9964Q34131651-11039C8E-A617-4E3D-943E-ECED8AA726D2Q34240893-072A86BA-B639-4358-98BB-C4A0FB2E4D91Q34571151-808D1C90-B6CA-490C-AC6F-BEF5DC186386Q34572441-8B1B8D8C-4ED2-4A70-9A2A-7D8C90C9B991Q34720407-7FA787A7-1497-4B6F-B391-16CC1FD07D54Q34722635-7F9FF7CB-A1C8-4A0E-A000-C3338AEA22E0Q34971386-A9068D1C-CE52-4E5D-9AC8-37629203BCB2Q35536504-9D97B140-76A6-4746-B125-C068270CE10DQ35563505-ED43CF4D-C9D1-42AE-9C6F-56B00CCA145AQ35563630-4139523C-EDA5-418D-A9AA-D85EE70D3F44Q35628419-815FA572-FB12-4614-B0BA-EB6F233993B6Q35738005-19BA2BFA-C920-478D-B3CD-17D23DF441BDQ36008360-5300A5B6-4126-4605-883B-7911E47A675AQ36241039-CCD9C09B-FE72-495F-80E8-F2C4AC30BC03Q36312169-E9745210-8090-401A-9C03-69F2D9D95F7CQ36440011-E0BC27E1-7311-44AB-900F-A67CB5F2C967Q36440015-E74FA6E8-9E33-4614-922D-C9A6BB222C10Q36503136-22114E45-D9EB-451B-B212-61E41FEE47A8Q36532607-BB292D2E-E4C8-428E-9940-B58AB37339FE
P2860
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Leukotrienes and airway responses.
@en
Leukotrienes and airway responses.
@nl
type
label
Leukotrienes and airway responses.
@en
Leukotrienes and airway responses.
@nl
prefLabel
Leukotrienes and airway responses.
@en
Leukotrienes and airway responses.
@nl
P2860
P356
P1476
Leukotrienes and airway responses
@en
P2093
P2860
P304
P356
10.1164/AJRCCM/136.4.985
P577
1987-10-01T00:00:00Z